Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease

CONCLUSIONS: These findings lend further support for exosomal changes in neurodegenerative disorders, and particularly in sAD. Further proteomic research could decisively advance our knowledge of sAD pathophysiology as much as it could foster the development of clinically meaningful biomarkers.PMID:38015424 | DOI:10.1097/WAD.0000000000000589
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Authors: Source Type: research